▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3630 by analyst upside · 2026-11-07
ISRG
Intuitive Surgical, Inc.
Healthcare · Market Cap $160B · P/E 54.8x
ANALYST PRICE TARGET
+6.6%
implied upside to consensus target
Current Price $452.8
Consensus Target $482.67
Bull Target $685.0
Bear Target $324.0
Analysts Covering 30
ANALYST CONSENSUS - BUY
Strong Buy
6
Buy
17
Hold
5
Sell
2
52-Week Low $328.57
52-Week High $603.88
YTD Return -19.4%
FUNDAMENTALS
Market Cap $160B
P/E Ratio (TTM) 54.8x
Forward P/E 36.3x
EPS (TTM) $8.27
PEG Ratio 2.11
Dividend Yield N/A
Revenue (TTM) $11.6B
Profit Margin 25.5%
52-WEEK RANGE
52-Week Low $328.57
52-Week High $603.88
Current Price $452.8
Bear Target $324.0
Bull Target $685.0
● Now $452.8 ● Target $482.67
TRADING DATA
Avg Volume 2.5M
YTD Return -19.4%
Analyst Count 30
Consensus Buy
Upside to Target +6.6%
Last Updated 2026-11-07

ANALYST SUMMARY

Intuitive Surgical, Inc. (ISRG) is currently trading at $452.8 with a Wall Street consensus price target of $482.67, implying potential upside of 6.6% over the next 12 months. 30 analysts currently cover ISRG, with a consensus rating of Buy - 77% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $685.0, while the most cautious has a target of $324.0.

ISRG operates in the Healthcare sector with a market capitalisation of $160B. The stock is down 19.4% year-to-date and is currently trading near the lower end of its 52-week range of $328.57 – $603.88.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ISRG, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Leerink Partners - Reiterated
Outperform → Outperform 2026-10-21 29% win rate (7 calls)
JP Morgan - Reiterated
Overweight → Overweight 2026-10-21 43% win rate (7 calls)
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-10-21 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-10-21 Building track record
TD Cowen reit
Buy → Buy 2026-10-21 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-10-21 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-10-21 Building track record
Mizuho - Reiterated
Neutral → Neutral 2026-10-21 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
54
out of 100
Coverage depth
26/30
Consensus clarity
14/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →